Intellectual Property

ENDACEA is an established biopharma company focused on the discovery and development of advanced medical solutions. Its inventions are protected, maintaining a high standard of professionalism and integrity.

U.S. Patent for "Methods and Pharmaceutical Compositions for Preventing and Treating Renal Impairment"

Claiming Priority to U.S. Provisional Application Filed 01/10

Issued 01/18, U.S. Patent 9,877,967 B2

U.S. Patent Application, "Compositions For and Methods of Treatment With Mutant A1 Adenosine Receptor Plasmid cDNAs"

Filed May 2, 2022; Patent Application Number 17/734,574